• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

BioIntelliSense

BioIntelliSense and Medically Home Partner to Enhance High Acuity Hospital Care at Home

by HITC Staff 11/10/2022 Leave a Comment

BioIntelliSense and Medically Home Partner to Enhance High Acuity Hospital Care at Home

What You Should Know: - BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced it has entered into a strategic partnership with Medically Home Group, Inc., a technology-enabled services company that is at the forefront of the movement to decentralize care for serious or complex illnesses. - The collaboration further expands the availability of continuous biometric data and insights to physicians and nurses caring for patients in the
Read More

BioIntelliSense Acquires Patient Monitoring Company AlertWatch

by Fred Pennic 10/18/2022 Leave a Comment

BioIntelliSense Acquires AlertWatch to Expand Continuous Patient Monitoring Solutions

What You Should Know: - BioIntelliSense, Inc. acquires AlertWatch, an FDA-cleared, clinically proven patient monitoring solution. AlertWatch uniquely provides robust integration, data analysis and a patented intuitive display of contextual patient data for more efficient, actionable clinical decisions. - As part of the recently announced strategic partnership with Medtronic, its Patient Monitoring business will distribute AlertWatch to hospitals throughout the U.S.
Read More

Medtronic-BioIntelliSense Partnership Expands Access to RPM Wearables

by Fred Pennic 08/31/2022 Leave a Comment

Medtronic-BioIntelliSense Partnership Expands Access to RPM Wearables

What You Should Know: - Medtronic announces partnership with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearable for continuous remote patient monitoring from in-hospital to home. - The partnership enables Medtronic to offer access to BioIntellSense’s BioButton® multi-parameter wearable device, which provides scalable personalized patient care, greater workflow automation and proactive clinical interventions for hospitals facing increasing costs and growing
Read More

Houston Methodist Taps BioIntelliSense to Advance Remote Care and Clinical Intelligence Solutions

by Provider Partnerships 05/02/2022 Leave a Comment

Houston Methodist Taps BioIntelliSense to Advance Remote Care and Clinical Intelligence Solutions

What You Should Know: - Houston Methodist and Colorado-based BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced a new collaboration to advance remote monitoring and analytics technologies across the healthcare continuum, from in-hospital to at-home. - BioIntelliSense’s FDA-cleared BioSticker™ and medical-grade BioButton® wearable devices, along with its algorithmic-based data services, enable effortless remote data capture and continuous
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |